Skip to main content
    I

    Inventiva Sa (IVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.11
    +0.24 (+8.36%)

    Market Cap: $677.95M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(10/21)
    Avg Surprise
    -45.55%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.16
    Range$-0.16 - $-0.16
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.23+30.9%
    60d ago$-0.19+16.3%
    30d ago$-0.19+16.3%
    7d ago$-0.19+16.3%
    Current$-0.16
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.06
    Range$-0.22 - $0.07
    6 analysts
    Revenue Consensus
    $376980
    Range$-3058500 - $8M
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.06---
    Sep 26EST
    		-$-0.16---
    Jun 26
    Reported Sep 28
    		$N/A$-0.20N/ABeat-
    Mar 26
    Reported May 25
    		$0.00N/A+100.00%Beat+100.0%
    Dec 25
    Reported Mar 30
    		$0.00N/A+100.00%Beat+100.0%
    Sep 25
    Reported Nov 21
    		$-0.30$-0.29-3.45%Miss+60.5%
    Jun 25
    Reported Sep 25
    		$-1.62$-0.60-167.86%Miss-85.9%
    Mar 25
    Reported May 23
    		$-2.00$-0.43-365.12%Miss-316.7%
    Dec 24
    Reported Mar 26
    		$-1.82$-0.43-323.26%Miss-183.8%
    Sep 24
    Reported Nov 21
    		$-0.76$-0.56-35.71%Miss+22.4%
    Jun 24
    Reported Sep 25
    		$-0.87$-0.63-37.74%Miss+37.3%
    Mar 24
    Reported May 21
    		$-0.48$-0.47-2.13%Miss-65.5%
    Dec 23
    Reported Mar 27
    		$-0.64$-0.40-60.30%Miss-132.5%
    Sep 23
    Reported Nov 21
    		$-0.98$-0.98+0.00%Beat-
    Jun 23
    Reported Sep 28
    		$-1.39$-1.39+0.00%Beat-
    Mar 23
    Reported May 16
    		$-0.29$-0.29+0.00%Beat-
    Dec 22
    Reported Mar 29
    		$-0.28$0.08-444.75%Miss-72.4%
    Sep 22
    Reported Nov 10
    		$0.00$0.00N/ABeat-
    Jun 22
    Reported Sep 19
    		$0.00$0.00N/ABeat-
    Mar 22
    Reported May 16
    		$0.00$0.00N/ABeat+100.0%
    Dec 21
    Reported Mar 3
    		$-0.16N/A+66.67%Beat+66.6%
    Sep 21
    Reported Nov 10
    		$0.00N/A+100.00%Beat+100.0%
    Jun 21
    Reported Sep 20
    		$0.00N/A+100.00%Beat+100.0%
    Mar 21
    Reported May 12
    		$-0.44$-0.33-32.33%Miss-62.4%
    Dec 20
    Reported Mar 4
    		$-0.48$-0.48+0.00%Beat-16.8%
    Sep 20
    Reported Nov 12
    		$-0.39$-0.38-3.94%Miss+62.7%
    Jun 20
    Reported Sep 16
    		$-0.21N/A+53.33%Beat-
    Mar 20
    Reported May 14
    		$-0.27$0.00N/AMiss+70.2%
    Dec 19
    Reported Dec 31
    		$-0.41N/AN/ABeat+58.9%
    Jun 19
    Reported Jun 30
    		$-1.05N/AN/ABeat-58.1%
    Mar 19
    Reported Jun 29
    		$0.00$0.00N/ABeat+100.0%
    Dec 18
    Reported Dec 31
    		$-0.91N/AN/ABeat-192.3%
    Jun 18
    Reported Jun 30
    		$-1.00N/AN/ABeat-
    Dec 17
    Reported Dec 31
    		$-0.67N/AN/ABeat-
    Jun 17
    Reported Jun 30
    		$-0.76N/AN/ABeat-
    Dec 16
    Reported Dec 31
    		$-0.31N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-3.30xFCF Yield-30.31%
    Profitability
    Profit Margin0.00%Operating Margin-5337.00%
    ROE-989.00%ROIC-321.70%
    Financial Health
    Debt/Equity1.13xInterest Coverage-5.56x
    Current Ratio3.81xQuick Ratio3.81x
    Trading Statistics
    Beta1.00Avg Volume2.82M
    52-Week High$7.9852-Week Low$2.82

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.23
    SMA 20$3.37
    SMA 50$4.08
    SMA 200$4.97
    EMA 10$3.18
    EMA 20$3.40
    EMA 50$3.84
    EMA 200$4.48

    MACD

    Line: -0.29Signal: -0.28Hist: -0.01

    ADX

    ADX: 28.7+DI: 16.4-DI: 26.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down96.0
    PSAR$3.66

    Bollinger Bands

    Upper Band$3.88
    Lower Band$2.87
    %B Position3004%(Upper)
    Band Width0.24

    RSI (14-Day)

    Neutral
    37.0

    Momentum Oscillators

    Stoch %K10.3
    Stoch %D5.2
    Williams %R-73.8
    ROC (10d)-10.1%
    Momentum-0.35
    CCI (20d)-106.2
    MFI (14d)36.8

    Volatility Measures

    ATR (14d)$0.25(8.1%)
    StdDev (20d)0.25
    Hist Vol82.1%(High)

    Volume Flow

    VWAP$3.08
    OBV-14.8M
    AD Line3.5M
    CMF (20d)-0.077

    Volume Metrics

    Avg Vol (20d)2.9M
    Vol Ratio1.0x
    VWMA (20d)$3.37

    Pivot Points

    R3$3.09
    R2$3.02
    R1$2.95
    Pivot Point$2.88
    S1$2.81
    S2$2.74
    S3$2.67

    Advanced Oscillators

    TSI-33.88
    Ultimate Osc41.7
    KST-222.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Jun 2023Mar 2023
    Total Revenue$1.30M$28,785$28,785$4.45M$6.46M$6.46M$2.73M$2.73M$16.54M$16.54M$6.62MN/A
    Cost of Revenue$458,000$1.20M$1.20M$1.70M$-526,000$-526,000$526,000N/A$558,000$558,000$459,000N/A
    Gross Profit$847,000$-1,169,280$-1,169,280$2.75M$6.99M$6.99M$2.21M$2.73M$15.98M$15.98M$6.16MN/A
    Operating Expenses$71.23M$77.77M$77.77M$59.55M$52.30M$52.30M$54.46M$54.98M$63.69M$63.69M$60.06MN/A
    R&D$46.86M$42.96M$42.96M$43.31M$44.06M$44.06M$46.82M$46.82M$55.95M$55.95M$54.06M$0
    SG&A$20.41M$0$33.17M$15.88M$7.57M$8.92M$7.14M$7.70M$6.54M$6.54M$6.34M$0
    Operating Income$-70,388,000$-74,144,540$-74,144,540$-56,802,000$-45,309,000$-45,309,000$-52,249,000$-52,249,000$-47,706,000$-47,706,000$-55,001,000N/A
    Interest Income$0$0$0$0$0$1.14M$0$0$0$0$0$0
    Interest Expense$14.67M$23.70M$23.70M$9.74M$12.18M$12.18M$5.69M$0$3.21M$6.84M$1.96M$0
    Income Before Tax$-69,363,000$-164,816,166$-164,816,166$-177,510,000$-134,991,000$-134,991,000$-48,910,000$-48,910,000$-54,543,000$-54,543,000$-55,276,000$0
    Income Tax Expense$104,000$-621,365$-621,365$-1,628,000$194,000$194,000$119,000$119,000$614,000$614,000$-7,000$-3,500
    Net Income$-70,402,072$-176,936,545$-176,936,545$-175,882,000$-135,183,000$-135,183,000$-49,029,000$-49,029,000$-55,157,000$-55,157,000$-55,269,000N/A
    EBITDA$-70,707,123$-77,738,288$-77,738,288$-165,841,000$-117,762,305$-114,707,000$-51,818,000$-51,818,000$-46,248,000$-47,985,000$-53,863,000N/A
    EBIT$-72,132,047$-78,936,353$-78,936,353$-167,545,000$-119,474,000$-119,474,000$-52,249,000$-52,249,000$-47,709,000$-47,709,000$-55,001,000$-27,500,500
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IVA

    News

    Inventiva Share: 2% Rise on Support Level, Among SBF 120's Strongest Performers

    Inventiva, a Burgundy biotech company, saw its share price rise by 2.06% to €2.72, making it one of the strongest performers in the SBF 120 despite a recent decline. This rebound occurs as the company's financial...

    Idéal Investisseur•10/15/26•Neutral

    Inventiva: Significant Upside Potential Ahead Of Pivotal Liver Disease Readout

    Inventiva (IVA) receives a speculative strong buy rating with a probability-weighted fair value of approximately $15 per share...

    Seeking Alpha•10/14/26•Bullish

    Inventiva among the largest declines on the SBF 120: stock falls 4.5%

    Inventiva, a Burgundy biotech specializing in fibrotic and metabolic diseases, saw its stock fall 4.5% on Tuesday...

    Idéal Investisseur•10/13/26•Bearish

    Inventiva: the stock, among the steepest declines on the SBF 120, drops 14.5% in one month

    Inventiva, a Burgundy biotech company specializing in fibrotic and metabolic diseases, has seen its stock drop significantly...

    Idéal Investisseur•10/13/26•Bearish

    Diluted net income available to common stockholders of Inventiva SA ADR – HAN:6IVA

    This article provides financial data for Inventiva SA ADR (HAN:6IVA) focusing on its diluted net income available to common stockholders. The content appears to be a stub or a section from a larger financial data...

    TradingView•10/12/26•Neutral

    IVA Valuation and Fair Value

    P/FCF
    -3.3x
    P/B
    12.6x
    See GNG's fair value

    IVA Profitability: Margins, ROIC and FCF

    Gross margin
    21.8%
    Operating margin
    -5337.0%
    Net margin
    0.0%
    ROIC
    -321.7%
    ROE
    -989.0%
    FCF margin
    -3260.0%
    FCF yield
    -30.3%

    IVA Competitors

    CompanyTicker
    Design Therapeutics IncDSGN
    4D Molecular Therapeutics IncFDMT
    MiMedx Group IncMDXG
    Pharming Group NVPHAR
    Gyre Therapeutics Inc.GYRE
    OmniAb Inc.OABI
    Annexon IncANNX
    Phreesia IncPHR

    Sector: Healthcare

    IVA Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    1
    Buy
    12
    Hold
    0
    Sell
    0
    Strong Sell
    0

    IVA Bull Case vs Bear Case

    Bull case

    • 100.0% of IVA's analyst ratings are Buy or Strong Buy.

    Bear case

    • IVA beat EPS estimates in 25.0% of its last 8 reported quarters.
    • IVA's quarterly revenue changed -76.7% year over year.

    IVA Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -91.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.16
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About IVA

    Does IVA pay dividends?

    Inventiva Sa (IVA) does not currently pay a regular dividend.

    What is IVA's market cap?

    Inventiva Sa (IVA) has a market capitalization of $677.95M with a current stock price of $3.11.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In